- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07740044
Medical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Chronic Disease Management
27 июля 2026 г. обновлено: Jiangsu Taizhou People's Hospital
Verification and Application Study of Medical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Chronic Disease Management: A Randomized Controlled Study
This study aims to explore the feasibility of using medical large language models to assist in chronic disease management.
By setting up experimental and control group interventions and having experts blindly evaluate anonymized cases, it compares different management approaches in chronic disease care, verifying the scientific basis, effectiveness, and potential for broader use of medical large language models in supporting chronic disease management.
Обзор исследования
Статус
Еще не набирают
Вмешательство/лечение
Тип исследования
Интервенционный
Регистрация (Оцененный)
20
Фаза
- Непригодный
Контакты и местонахождение
В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.
Контакты исследования
- Имя: Guoyu Wang, MD
- Номер телефона: +8615951154720
- Электронная почта: wangguoyutzheart@163.com
Места учебы
-
-
Jiangsu
-
Taizhou, Jiangsu, Китай, 225300
- The Affiliated Taizhou People's Hospital of Nanjing Medical University
-
Контакт:
- Guoyu Wang, MD
- Номер телефона: +8615951154720
- Электронная почта: wangguoyutzheart@163.com
-
-
Критерии участия
Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.
Критерии приемлемости
Возраст, подходящий для обучения
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Нет
Описание
Inclusion Criteria:
- Work experience of 3 years or more;
- Able to complete the case assessment tasks required by the study;
- Have a practicing doctor qualification;
- Work at a township health center or community health service center;
- Voluntarily participate in the study and sign the informed consent form.
Exclusion Criteria:
N/A
Учебный план
В этом разделе представлена подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.
Как устроено исследование?
Детали дизайна
- Основная цель: Другой
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Активный компаратор: LLM-Assisted Intervention Group
Primary care doctors creating management plans for chronic diseases (coronary heart disease, atrial fibrillation, heart failure, stroke) with the help of large medical language models
|
The primary care physicians in the intervention group completed the management decisions for chronic disease cases, including disease assessment, examination suggestions, treatment plans, selection of management methods, and health education, with the assistance of the medical LLM.
|
|
Без вмешательства: Usual Care Control Group
Primary care doctors creating management plans for chronic diseases (coronary heart disease, atrial fibrillation, heart failure, stroke) without the help of a large medical language model
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
expert overall scores
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
They rated them using a Likert scale on several aspects: accuracy of condition assessment, reasonableness of test recommendations, reasonableness of treatment plans, appropriateness of management choices, scientific nature of patient education content, feasibility at the primary care level, overall clinical quality.
Experts were instructed to rank the seven dimensions from lowest to highest quality.
These ordinal rankings were then converted into standardized scores of 1 to 5. Higher scores mean better.
|
through study completion, an average of 3 months.
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
accuracy of condition assessment
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
They rated them using a Likert scale on accuracy of condition assessment from lowest to highest quality.
These ordinal rankings were then converted into standardized scores of 1 to 5. Higher scores mean better.
|
through study completion, an average of 3 months.
|
|
reasonableness of test recommendations
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
They rated them using a Likert scale regarding the reasonableness of test recommendations.
Experts were instructed to rank the dimension from lowest to highest quality.
These ordinal rankings were then converted into standardized scores of 1 to 5. Higher scores mean better.
|
through study completion, an average of 3 months.
|
|
reasonableness of treatment plans
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
They rated them using a Likert scale regarding the reasonableness of treatment plans.
Experts were instructed to rank the dimension from lowest to highest quality.
These ordinal rankings were then converted into standardized scores of 1 to 5. Higher scores mean better.
|
through study completion, an average of 3 months.
|
|
appropriateness of management choices
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
They rated them using a Likert scale regarding the ppropriateness of management choices.
Experts were instructed to rank the dimension from lowest to highest quality.
These ordinal rankings were then converted into standardized scores of 1 to 5. Higher scores mean better.
|
through study completion, an average of 3 months.
|
|
scientific nature of patient education content
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
They rated them using a Likert scale regarding the scientific nature of patient education content.
Experts were instructed to rank the dimension from lowest to highest quality.
These ordinal rankings were then converted into standardized scores of 1 to 5. Higher scores mean better.
|
through study completion, an average of 3 months.
|
|
feasibility at the primary care level
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
They rated them using a Likert scale regarding the feasibility at the primary care level.
Experts were instructed to rank the dimension from lowest to highest quality.
These ordinal rankings were then converted into standardized scores of 1 to 5. Higher scores mean better.
|
through study completion, an average of 3 months.
|
|
the overall clinical quality
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
They rated them using a Likert scale regarding the overall clinical quality.
Experts were instructed to rank the dimension from lowest to highest quality.
These ordinal rankings were then converted into standardized scores of 1 to 5. Higher scores mean better.
|
through study completion, an average of 3 months.
|
|
risk advice
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
If there is no risk advice, the expert selects 'No'; otherwise, the expert selects 'Yes' and specifically lists the content of the risk advice.
|
through study completion, an average of 3 months.
|
|
Any diagnostic or treatment information missing
Временное ограничение: through study completion, an average of 3 months.
|
A total of 200 cases (50 each of coronary heart disease, atrial fibrillation, heart failure, and stroke) were grouped by disease type and independently evaluated in a blinded manner by three subspecialty experts.
For each case, the two management plans were anonymized in the same way and then randomly labeled by a computer as Plan A and Plan B. Experts could only view the anonymized case information and the two corresponding anonymized management plans.
If there is no omission of diagnostic and treatment information, the expert selects "No"; otherwise, the expert selects "Yes" and specifically lists the omitted diagnostic and treatment content.
|
through study completion, an average of 3 months.
|
|
feedback regarding the use of medical LLM by primary care physicians
Временное ограничение: through study completion, an average of 3 months.
|
After primary care physicians complete a case assessment assisted by medical LLM , they will fill out an evaluation of the medical LLM usage, including whether the medical LLM helped in disease assessment, assisted in formulating examination plans, aided in developing treatment plans, improved chronic disease management capabilities, supported chronic disease education, assisted in management approach selection, enhanced confidence, saved time, whether there were hallucinations or omissions, whether it provided risky suggestions, and any additional comments on the use of the medical LLM.
|
through study completion, an average of 3 months.
|
Соавторы и исследователи
Здесь вы найдете людей и организации, участвующие в этом исследовании.
Даты записи исследования
Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.
Изучение основных дат
Начало исследования (Оцененный)
17 августа 2026 г.
Первичное завершение (Оцененный)
30 сентября 2026 г.
Завершение исследования (Оцененный)
30 ноября 2026 г.
Даты регистрации исследования
Первый отправленный
20 июля 2026 г.
Впервые представлено, что соответствует критериям контроля качества
27 июля 2026 г.
Первый опубликованный (Действительный)
31 июля 2026 г.
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
31 июля 2026 г.
Последнее отправленное обновление, отвечающее критериям контроля качества
27 июля 2026 г.
Последняя проверка
1 июля 2026 г.
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
- Цереброваскулярные расстройства
- Заболевания головного мозга
- Заболевания центральной нервной системы
- Заболевания нервной системы
- Сосудистые заболевания
- Сердечно-сосудистые заболевания
- Патологические процессы
- Сердечные заболевания
- Аритмии, Сердечные
- Артериосклероз
- Артериальные окклюзионные заболевания
- Коронарная болезнь
- Ишемия миокарда
- Патологические состояния, признаки и симптомы
- Инсульт
- Сердечная недостаточность
- Мерцательная аритмия
- Ишемическая болезнь сердца
Другие идентификационные номера исследования
- LSKY 2026-114-01
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
НЕТ
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Нет
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Нет
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .